Product Information
NP THYROID 30 MG TABLET is a generic product labeled by Acella Pharmaceuticals, LLC, priced at $0.5917 per EA under NDC 42192032901. Its NADAC has been published 481 times since Apr 19, 2017.
Strength
19; 4.5 ug/1; ug/1
Manufacturer
Acella Pharmaceuticals, LLCNDC
42192032901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVOTHYROXINE; LIOTHYRONINEApproval Type
Unapproved
On Market Since
1/14/2011
Pharmacological Classes
Price Statistics
The NADAC for NP THYROID 30 MG TABLET has been published 481 times since Apr 19, 2017, and over the history we have for it it has risen 42.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5917 per EA |
|---|---|
| All-time high | $0.6535 (Feb 14, 2024) |
| All-time low | $0.3888 (Apr 18, 2018) |
| 52-week high | $0.5962 |
| 52-week low | $0.5717 |
| Median price | $0.5806 |
| Average price | $0.5557 |
| Largest weekly change | -14.5% (Apr 17, 2024) |
| Weeks tracked | 481 |
| Tracking since | Apr 19, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Acella Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LEVOTHYROXINE, LIOTHYRONINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
l-Thyroxine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NP THYROID 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NP THYROID 30 MG TABLET, manufactured by Acella Pharmaceuticals, LLC, is $0.5917 per EA (NDC 42192032901), effective Sep 30, 2026.
How has the price of NP THYROID 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for NP THYROID 30 MG TABLET has risen 42.6%. It has been tracked across 481 weekly CMS publications since Apr 19, 2017.
What are the highest and lowest recorded NADAC prices for NP THYROID 30 MG TABLET?
Since Apr 19, 2017, the NADAC for NP THYROID 30 MG TABLET has ranged from a low of $0.3888 (Apr 18, 2018) to a high of $0.6535 (Feb 14, 2024), with a median of $0.5806 per EA.
Are there cheaper alternatives to NP THYROID 30 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NP THYROID 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NP THYROID 30 MG TABLET?
NP THYROID 30 MG TABLET (NDC 42192032901) is labeled by Acella Pharmaceuticals, LLC, and CMS classifies it as a generic product.